Industry Insights with Crown Bioscience: Analyzing the Suppressive TME in In Vitro Based AssaysDarius Soo Lum
Nataliia Beztsinna and Marten Hornsveld from Crown Bioscience talk about native and reconstituted TME assays, how they can help in the preparation for clinical trials, and what kinds of therapies in development would benefit the most from this kind of testing.
Industry Insights with Crown Bioscience: Targeting T Cells Within the Cancer-Immunity Cycle
In this episode of Industry Insights, Saskia De Man, PhD, Marrit Putker, PhD, and Pirouz Daftarian, PhD, from Crown Bioscience discuss assays and methods for evaluating T cell therapeutics, including organoids, co-cultures, and high content imaging.
Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle
In this episode of Industry Insights, Rajendra Kumari, PhD, and Gera Goverse, PhD, from Crown Bioscience answer questions about in vivo, in vitro, and ex vivo technologies and methods that can be used for immuno-oncology research along each step of the cancer-immunity cycle.
Industry Insights with Chris Rand from Aurora Scientific
This episode of Share Science features Chris Rand, MSc, sales and marketing manager at Aurora Scientific. In this interview, Chris shares Aurora Scientific’s history, their journey within the preclinical research world, and their advance into the neuroscience space.
Industry Insights with Chris Rand from Aurora ScientificDarius Soo Lum
Chris Rand delves into the start and evolution of Aurora Scientific, and their journey within the preclinical research world.
Industry Insights with Amy Sheng on Nanobodies
This episode of Share Science features Amy Sheng from Sino Biological, who shares how nanobodies are expected to revolutionize antibody-based drug therapies for a wide range of pathological conditions and especially cancer immunotherapy!
Industry Insights with Trent Lund on the ANY-maze Operant Interface
This episode of Share Science features Trent Lund from Stoelting Co., who shares some of Stoelting's latest developments such as the deceptively simple and surprisingly powerful ANY-maze, a behavioral tracking software!
Industry Insights with Amy Sheng on Nanobodies: An Important Tool for the Next Generation of Tumor Diagnostics and TherapeuticsDarius Soo Lum
Amy Sheng shares how nanobodies are emerging as important tools for tumor diagnosis and treatment.
Industry Insights with Trent Lund on the ANY-maze Operant InterfaceDarius Soo Lum
Trent Lund shares the latest and greatest developments in the ANY-maze Operant Interface, and gives us insight on how Stoelting has created the most inclusive line of neuroscience equipment in the industry.
Industry Insights with Yuning Chen on Recombinant Proteins
This episode of Share Science features Yuning Chen from Sino Biological, who provides insights into their extensive library of recombinant virus proteins, as well as the importance and value of these high quality reagents!
Industry Insights with Yuning Chen on Recombinant ProteinsDarius Soo Lum
Yuning Chen discusses The “ProVir™” collection and the role of recombinant virus proteins in the development of infectious disease treatment regimes and vaccines.